Company Analysis

Strata Critical Medical, Inc. (SRTA)

Nasdaq: SRTA · Services-Health Services · New York, NY · filing with the SEC since 2019
Grade5.3
◀ Past 5.1● Present 5.1▶ Future 5.8
1 est.

Filings

229 filings since 2017 beside 346 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Apr 14, 2026.

Filings a yearinsider forms included
271510882841028869
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Dec 3, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 22, 2024.
Insider forms 346

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 3, 2026 10-Q Quarterly report Sep 30, 2026
Nov 3, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 15, 2026 SCHEDULE 13D Activist holder notice
Aug 20, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 4, 2026 10-Q Quarterly report Jun 30, 2026
Aug 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 8, 2026 SCHEDULE 13G/A Large holder update, amended
Jun 17, 2026 SCHEDULE 13G Large holder notice
Jun 3, 2026 8-K item 5.07 Shareholder vote · Current report May 28, 2026
May 8, 2026 SCHEDULE 13D/A Activist holder update, amended
May 6, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 25-NSE Delisting notice from the exchange
Apr 30, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 16, 2026 SCHEDULE 13D/A Activist holder update, amended
Apr 14, 2026 DEFA14A Extra proxy material
Apr 14, 2026 DEF 14A Proxy statement May 28, 2026
Apr 8, 2026 SCHEDULE 13D/A Activist holder update, amended
Apr 7, 2026 SCHEDULE 13D Activist holder notice
Mar 3, 2026 10-K Annual report Dec 31, 2025
Mar 3, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 5, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Jan 30, 2026
Jan 21, 2026 SCHEDULE 13G Large holder notice
Dec 3, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Dec 2, 2025
Dec 2, 2025 8-K/A items 2.01, 9.01 Purchase or sale of a business completed · Current report, amended Sep 16, 2025
Nov 21, 2025 S-8 Employee stock plan registration
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 10, 2025 10-Q Quarterly report Sep 30, 2025
Nov 10, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 4, 2025 SCHEDULE 13G/A Large holder update, amended
Oct 17, 2025 SCHEDULE 13G/A Large holder update, amended
Sep 12, 2025 8-K/A item 5.07 Shareholder vote · Current report, amended May 8, 2025
Aug 29, 2025 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended Aug 1, 2025
Aug 11, 2025 SCHEDULE 13G Large holder notice
Aug 5, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 4, 2025 8-K items 1.01, 5.02, 7.01, 9.01 Major agreement signed; Officer or director change; Investor disclosure (Regulation FD) · Current report Aug 1, 2025
Jul 17, 2025 SCHEDULE 13G Large holder notice
40 of 229 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton SRTA · research, not advice